首页> 外文OA文献 >PRM86 Estimating the Lifetime Health Outcomes of Type 2 Diabetes Mellitus (T2dm) Patients Inadequately Controlled on Metformin Plus Sulphonylurea Receiving Either Canagliflozin or Sitagliptin Using the UKPDS Outcomes Model V1.3

【2h】

PRM86 Estimating the Lifetime Health Outcomes of Type 2 Diabetes Mellitus (T2dm) Patients Inadequately Controlled on Metformin Plus Sulphonylurea Receiving Either Canagliflozin or Sitagliptin Using the UKPDS Outcomes Model V1.3

机译：PRM86评估使用UKPDS结果模型V1.3接受卡那列净或西格列汀治疗的二甲双胍+磺脲类药物未充分控制的2型糖尿病（T2dm）患者的终生健康结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Nuhoho S.; Worbes-Cerezo M;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) [J] . P. M. Clarke, A. M. Gray, A. Briggs, Diabetologia . 2004,第10期

机译：评估2型糖尿病患者终生健康结局的模型：英国前瞻性糖尿病研究（UKPDS）结果模型（UKPDS第68号）
2. Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial (vol 67, pg 1267, 2013) [J] . Davies M. J., Trujillo A., Vijapurkar U., Diabetes, obesity & metabolism . 2015,第7期

机译：卡那列净在二甲双胍和磺脲类药物控制不充分的2型糖尿病患者中的疗效和安全性：一项随机试验（第67卷，第1267页，2013年）
3. Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: A randomised trial [J] . WildingJ.P.H., CharpentierG., HollanderP., International journal of clinical practice . 2013,第12期

机译：用二甲双胍和磺酰脲对2型糖尿病患者羊皮脂蛋白患者的疗效和安全性：随机试验
4. Relationship of therapeutic outcome with quality of life on type 2 diabetes mellitus patients in Abdul Azis Singkawang hospital [C] . D A Perwitasari, S Urbayatun, I N Faridah International Pharmacy Conference . 2018

机译：Abdul Azis Singkawang医院2型糖尿病患者的生活质量治疗结果的关系
5. The relationship of health locus of control, health value, and perceived health competence to Type 2 diabetes mellitus outcomes. [D] . Eckleberry, Jodie Gail. 2000

机译：健康控制源，健康价值和感知的健康能力与2型糖尿病结局的关系。
6. Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients [O] . Luca Degli Esposti, Stefania Saragoni, Stefano Buda, 2014

机译：不可控制的2型糖尿病患者将二甲双胍与西他列汀或磺脲类药物或噻唑烷二酮类药物合用的临床结果和医疗保健费用
7. PDB5 Network Meta-Analysis (NMA) to Assess Relative Efficacy Measured as Percentage of Patients Treated to HbA1c Target with Canagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled on Metformin and Sulphonylurea (MET+SU) [O] . Taieb V, Pacou M, Schroeder M, 2015

机译：PDB5网络荟萃分析（NMA）评估相对效力，以Canagliflozin治疗HbA1c靶点的患者在2型糖尿病（T2DM）患者中对二甲双胍和磺脲类药物（MET + SU）的控制不足

PRM86 Estimating the Lifetime Health Outcomes of Type 2 Diabetes Mellitus (T2dm) Patients Inadequately Controlled on Metformin Plus Sulphonylurea Receiving Either Canagliflozin or Sitagliptin Using the UKPDS Outcomes Model V1.3

著录项

相似文献

相关主题

期刊订阅